Similar articles

• Human papillomavirus vaccines: an update for gynecologists.

  Ault KA. Ault KA. Clin Obstet Gynecol. 2008 Sep;51(3):527-32. doi: 10.1097/GRF.0b013e31818092df. Clin Obstet Gynecol. 2008. PMID: 18677145 Review.
• Models of cervical screening in the era of human papillomavirus vaccination.

  Canfell K. Canfell K. Sex Health. 2010 Sep;7(3):359-67. doi: 10.1071/SH10016. Sex Health. 2010. PMID: 20719228
• National survey of general practitioners' experience of delivering the National Human Papillomavirus Vaccination Program.

  Brotherton JM, Leask J, Jackson C, McCaffery K, Trevena LJ. Brotherton JM, et al. Sex Health. 2010 Sep;7(3):291-8. doi: 10.1071/SH09135. Sex Health. 2010. PMID: 20719217
• Unresolved questions concerning human papillomavirus infection and transmission: a modelling perspective.

  Regan DG, Philp DJ, Waters EK. Regan DG, et al. Sex Health. 2010 Sep;7(3):368-75. doi: 10.1071/SH10006. Sex Health. 2010. PMID: 20719229 Review.
• US physicians' intentions regarding impact of human papillomavirus vaccine on cervical cancer screening.

  Wong C, Berkowitz Z, Saraiya M, Wideroff L, Benard VB. Wong C, et al. Sex Health. 2010 Sep;7(3):338-45. doi: 10.1071/SH09115. Sex Health. 2010. PMID: 20719225